Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dultavax + Vaxigrip
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Dultavax + Vaxigrip refers to the co-administration of two separate vaccines manufactured by Sanofi Pasteur, primarily utilized in clinical research to evaluate immune responses and potential interactions. Dultavax is a trivalent booster vaccine containing reduced-dose diphtheria toxoid, tetanus toxoid, and inactivated poliovirus (types 1, 2, and 3), indicated for active immunization in adults and children from 6 years of age. Vaxigrip is an inactivated influenza vaccine (traditionally trivalent) used for the prevention of seasonal flu. This specific combination has been utilized in studies examining the impact of iron deficiency anemia on vaccine efficacy in populations such as young women in Morocco. Both vaccines are biologics administered via intramuscular injection.
- Other names
- diphtheria, tetanus, and poliomyelitis (inactivated) vaccine + influenza vaccine
02
Targets
Diphtheria toxinHA (Hemagglutinin)PV3 (Sabin) (Poliovirus type 3 antigen)
Beyond the preview
Go deeper on Dultavax + Vaxigrip.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dultavax + Vaxigrip.